Key Information
Source
summary/abstract
- Life expectancy for people with ATTR amyloidosis varies, generally ranging from 3 to 15 years after symptoms appear, and depends on the specific type of the condition and any other health issues a person has.
- Early detection of ATTR amyloidosis and prompt treatment can significantly improve a person’s life expectancy by slowing down the disease’s progression.
- While there is currently no cure, new treatments such as tafamidis have shown promise in improving survival rates, particularly when people start treatment early.